Target Price | $95.37 |
Price | $94.95 |
Potential |
0.44%
register free of charge
|
Number of Estimates | 20 |
20 Analysts have issued a price target Merus N.V. 2026 .
The average Merus N.V. target price is $95.37.
This is
0.44%
register free of charge
$117.60
23.85%
register free of charge
$66.66
29.79%
register free of charge
|
|
A rating was issued by 23 analysts: 10 Analysts recommend Merus N.V. to buy, 13 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Merus N.V. stock has an average upside potential 2026 of
0.44%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 36.13 | 53.21 |
17.79% | 47.26% | |
EBITDA Margin | -746.19% | -726.91% |
112.94% | 2.58% | |
Net Margin | -595.99% | -866.34% |
69.06% | 45.36% |
21 Analysts have issued a sales forecast Merus N.V. 2025 . The average Merus N.V. sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Merus N.V. EBITDA forecast 2025. The average Merus N.V. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 Merus N.V. Analysts have issued a net profit forecast 2025. The average Merus N.V. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.35 | -6.10 |
11.67% | 82.09% | |
P/E | negative | |
EV/Sales | 121.90 |
19 Analysts have issued a Merus N.V. forecast for earnings per share. The average Merus N.V. EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Leerink Partners |
Locked
➜
Locked
|
Locked | Oct 06 2025 |
LifeSci Capital |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
UBS |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
Analyst Rating | Date |
---|---|
Locked
Leerink Partners:
Locked
➜
Locked
|
Oct 06 2025 |
Locked
LifeSci Capital:
Locked
➜
Locked
|
Sep 30 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 30 2025 |
Locked
UBS:
Locked
➜
Locked
|
Sep 30 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Sep 30 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Sep 30 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.